2α,3α-Epithio-5α-androstan-17β-yl 1-methoxycyclopentyl ether (10364-s), a new orally active anti-estrogenic steroid
- 30 June 1974
- Vol. 23 (6) , 929-937
- https://doi.org/10.1016/0039-128x(74)90065-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 2α,3α-epithio-5α-androstan-17β-ol in the treatment of advanced breast cancer. Japanese cooperative group of hormonal treatment for breast cancerCancer, 1973
- Epithioandrostanol (10275-S), an Estrogen AntagonistEndocrinologia Japonica, 1973
- 2α, 3α-EPITHIO-5α-ANDROSTAN-17β-OI IN TREATMENT OF CHRONIC MASTOPATHYEndocrinologia Japonica, 1968
- THE ESTROGEN-STIMULATION OF MAMMARY GROWTH IN OVARIECTOMIZED IMMATURE MICE AND THEIR INHIBITION BY STEROIDSEndocrinologia Japonica, 1968
- THE MECHANISM OF IN VIVO VAGINAL TTC REDUCTION STIMULATED BY ESTROGEN IN SPAYED MICEEndocrinologia Japonica, 1965
- Antitumor Efficacy of FluoxymesteroneArchives of internal medicine (1960), 1961
- ANTI-ESTROGEN ASSAY OF NEUTRAL STEROIDS ADMINISTERED BY SUBCUTANEOUS INJECTION12Endocrinology, 1961
- Hormonal therapy in cancer of the breast, XIII. The effect of 9α-fluoro-17α-methyl-Δ4-androsten-3-one-11β,17β-diol (fluoxymesterone) therapy on clinical course and hormonal excretionCancer, 1958
- Fluoxymesterone in the treatment of advanced breast cancerCancer, 1957